IO Biotech Statistics

Total Valuation

IO Biotech has a market cap or net worth of $90.92 million. The enterprise value is -$24.75 million.

Market Cap	90.92M
Enterprise Value	-24.75M

Important Dates

The last earnings date was Tuesday, May 14, 2024, before market open.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

IO Biotech has 65.88 million shares outstanding. The number of shares has increased by 128.63% in one year.

Shares Outstanding	65.88M
Shares Change (YoY)	+128.63%
Shares Change (QoQ)	+51.31%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	81.76%
Float	25.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.79
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.24, with a Debt / Equity ratio of 0.02.

Current Ratio	11.24
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.30% and return on invested capital (ROIC) is -79.57%.

Return on Equity (ROE)	-69.30%
Return on Assets (ROA)	-62.20%
Return on Capital (ROIC)	-79.57%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IO Biotech has paid $861,000 in taxes.

Income Tax	861,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.02% in the last 52 weeks. The beta is 0.55, so IO Biotech's price volatility has been lower than the market average.

Beta (1Y)	0.55
52-Week Price Change	-32.02%
50-Day Moving Average	1.57
200-Day Moving Average	1.52
Relative Strength Index (RSI)	39.34
Average Volume (30 Days)	99,525

Short Selling Information

The latest short interest is 39,533, so 0.06% of the outstanding shares have been sold short.

Short Interest	39,533
Short Previous Month	61,842
Short % of Shares Out	0.06%
Short % of Float	0.15%
Short Ratio (days to cover)	0.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.72M
Pretax Income	-87.64M
Net Income	-88.50M
EBITDA	-86.84M
EBIT	-87.64M
Earnings Per Share (EPS)	-$1.79

Full Income Statement

Balance Sheet

The company has $117.98 million in cash and $2.32 million in debt, giving a net cash position of $115.67 million or $1.76 per share.

Cash & Cash Equivalents	117.98M
Total Debt	2.32M
Net Cash	115.67M
Net Cash Per Share	$1.76
Equity / Book Value	115.47M
Book Value Per Share	1.75
Working Capital	113.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.98 million and capital expenditures -$186,000, giving a free cash flow of -$82.17 million.

Operating Cash Flow	-81.98M
Capital Expenditures	-186,000
Free Cash Flow	-82.17M
FCF Per Share	-$1.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IO Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-128.63%
Shareholder Yield	-128.63%
Earnings Yield	-97.34%
FCF Yield	-90.37%

Analyst Forecast

The average price target for IO Biotech is $9.67, which is 600.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.67
Price Target Difference	600.73%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.46%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2